These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38494153)

  • 1. Use of dual biologic therapy targeting the Th2 and Th17 axes simultaneously to treat patients with atopic dermatitis and concomitant psoriasis, psoriatic arthritis, or inflammatory bowel disease.
    Hren MG; Guenin S; Khattri S
    J Am Acad Dermatol; 2024 Jul; 91(1):138-140. PubMed ID: 38494153
    [No Abstract]   [Full Text] [Related]  

  • 2. Exacerbation of atopic dermatitis symptoms by ustekinumab in psoriatic patients with elevated serum immunoglobulin E levels: Report of two cases.
    Ishiuji Y; Umezawa Y; Asahina A; Fukuta H; Aizawa N; Yanaba K; Nakagawa H
    J Dermatol; 2018 Jun; 45(6):732-734. PubMed ID: 29569296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent Atopic Dermatitis and Psoriasis Vulgaris: Implications for Targeted Biologic Therapy.
    Johnson MC; Bowers NL; Strowd LC
    Cutis; 2022 Feb; 109(2):110-112. PubMed ID: 35659797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psoriasis or atopic eczema: skin-infiltrating effector memory T cells make the difference].
    Homey B
    Hautarzt; 2012 Jan; 63(1):52. PubMed ID: 22212158
    [No Abstract]   [Full Text] [Related]  

  • 5. Mutual antagonism of T cells causing psoriasis and atopic eczema.
    Eyerich S; Onken AT; Weidinger S; Franke A; Nasorri F; Pennino D; Grosber M; Pfab F; Schmidt-Weber CB; Mempel M; Hein R; Ring J; Cavani A; Eyerich K
    N Engl J Med; 2011 Jul; 365(3):231-8. PubMed ID: 21774711
    [No Abstract]   [Full Text] [Related]  

  • 6. Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD study.
    Pugliese D; Daperno M; Fiorino G; Savarino E; Mosso E; Biancone L; Testa A; Sarpi L; Cappello M; Bodini G; Caprioli F; Festa S; Laino G; Maconi G; Mazzuoli S; Mocci G; Sartini A; D'Amore A; Alivernini S; Gremese E; Armuzzi A
    Dig Liver Dis; 2019 Jul; 51(7):972-977. PubMed ID: 30992173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization.
    Noda S; Suárez-Fariñas M; Ungar B; Kim SJ; de Guzman Strong C; Xu H; Peng X; Estrada YD; Nakajima S; Honda T; Shin JU; Lee H; Krueger JG; Lee KH; Kabashima K; Guttman-Yassky E
    J Allergy Clin Immunol; 2015 Nov; 136(5):1254-64. PubMed ID: 26428954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of psoriasis/psoriatic arthritis with inflammatory bowel disease influences management strategy.
    Shaw CA; Kole LCS; Elewski BE
    J Eur Acad Dermatol Venereol; 2019 Nov; 33(11):e431-e432. PubMed ID: 31220373
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel combination biologic therapy for recalcitrant psoriasis and psoriatic arthritis in a medically complex patient.
    Hanna S; Youssef P; Lowe P
    Australas J Dermatol; 2022 Feb; 63(1):e63-e66. PubMed ID: 34813085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. So close, and yet so far away: The dichotomy of the specific immune response and inflammation in psoriasis and atopic dermatitis.
    Schäbitz A; Eyerich K; Garzorz-Stark N
    J Intern Med; 2021 Jul; 290(1):27-39. PubMed ID: 33428274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent Atopic Dermatitis and Psoriasis Successfully Treated With Dual Biologic Therapy.
    Kaszycki MA; Pixley JN; Feldman SR
    Cutis; 2023 Sep; 112(3):E13-E16. PubMed ID: 37903395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atopic dermatitis in Chinese patients shows T
    Chan TC; Sanyal RD; Pavel AB; Glickman J; Zheng X; Xu H; Cho YT; Tsai TF; Wen HC; Peng X; Cueto I; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2018 Sep; 142(3):1013-1017. PubMed ID: 29964056
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunologic Overlap of Helper T-Cell Subtypes 17 and 22 in Erythrodermic Psoriasis and Atopic Dermatitis.
    Moy AP; Murali M; Kroshinsky D; Duncan LM; Nazarian RM
    JAMA Dermatol; 2015 Jul; 151(7):753-60. PubMed ID: 25760640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early-onset pediatric atopic dermatitis is T
    Esaki H; Brunner PM; Renert-Yuval Y; Czarnowicki T; Huynh T; Tran G; Lyon S; Rodriguez G; Immaneni S; Johnson DB; Bauer B; Fuentes-Duculan J; Zheng X; Peng X; Estrada YD; Xu H; de Guzman Strong C; Suárez-Fariñas M; Krueger JG; Paller AS; Guttman-Yassky E
    J Allergy Clin Immunol; 2016 Dec; 138(6):1639-1651. PubMed ID: 27671162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined Biologic Therapy in 2 Patients With Severe Psoriasis and Severe Atopic Dermatitis.
    Pascual Ares M; Orbea Sopeña A; Aramburu González A; Gardeazábal García J
    Actas Dermosifiliogr; 2024 May; 115(5):527-529. PubMed ID: 37848132
    [No Abstract]   [Full Text] [Related]  

  • 16. Atopic dermatitis and psoriasis: two different immune diseases or one spectrum?
    Guttman-Yassky E; Krueger JG
    Curr Opin Immunol; 2017 Oct; 48():68-73. PubMed ID: 28869867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment.
    Guttman-Yassky E; Krueger JG; Lebwohl MG
    Exp Dermatol; 2018 Apr; 27(4):409-417. PubMed ID: 28266782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of IL-23 Inhibitors for the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review.
    Yang K; Oak ASW; Elewski BE
    Am J Clin Dermatol; 2021 Mar; 22(2):173-192. PubMed ID: 33301128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etanercept downregulates the Th17 pathway and decreases the IL-17+/IL-10+ cell ratio in patients with psoriasis vulgaris.
    Antiga E; Volpi W; Cardilicchia E; Maggi L; Filì L; Manuelli C; Parronchi P; Fabbri P; Caproni M
    J Clin Immunol; 2012 Dec; 32(6):1221-32. PubMed ID: 22699761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consideration of confounders, accuracy of diagnosis, and disease severity in assessing the risk of inflammatory bowel disease in patients with psoriasis and psoriatic arthritis/ankylosing spondylitis beginning interleukin-7 inhibitor treatment: comment on the article by Penso et al.
    Yang CR; Ker A; Kao PE; Wei JC
    Arthritis Rheumatol; 2022 Mar; 74(3):546-547. PubMed ID: 34463055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.